455 related articles for article (PubMed ID: 8344982)
1. Type IV collagenase(s) and TIMPs modulate endothelial cell morphogenesis in vitro.
Schnaper HW; Grant DS; Stetler-Stevenson WG; Fridman R; D'Orazi G; Murphy AN; Bird RE; Hoythya M; Fuerst TR; French DL
J Cell Physiol; 1993 Aug; 156(2):235-46. PubMed ID: 8344982
[TBL] [Abstract][Full Text] [Related]
2. Expression of tissue-type plasminogen activator and its inhibitor couples with development of capillary network by human microvascular endothelial cells on Matrigel.
Ito K; Ryuto M; Ushiro S; Ono M; Sugenoya A; Kuraoka A; Shibata Y; Kuwano M
J Cell Physiol; 1995 Feb; 162(2):213-24. PubMed ID: 7822431
[TBL] [Abstract][Full Text] [Related]
3. Leukemic cells (HL-60) produce a novel extracellular matrix-degrading proteinase that is not inhibited by tissue inhibitors of matrix metalloproteinases (TIMPs).
Dittmann KH; Lottspeich F; Ries C; Petrides PE
Exp Hematol; 1995 Feb; 23(2):155-60. PubMed ID: 7828672
[TBL] [Abstract][Full Text] [Related]
4. Studies on the effects of laminin, E-8 fragment of laminin and synthetic laminin peptides PA22-2 and YIGSR on matrix metalloproteinases and tissue inhibitor of metalloproteinase expression.
Mackay AR; Gomez DE; Nason AM; Thorgeirsson UP
Lab Invest; 1994 Jun; 70(6):800-6. PubMed ID: 8015284
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of AIDS-Kaposi's sarcoma cell induced endothelial cell invasion by TIMP-2 and a synthetic peptide from the metalloproteinase propeptide: implications for an anti-angiogenic therapy.
Benelli R; Adatia R; Ensoli B; Stetler-Stevenson WG; Santi L; Albini A
Oncol Res; 1994; 6(6):251-7. PubMed ID: 7532474
[TBL] [Abstract][Full Text] [Related]
6. Patterns of expression of metalloproteinases and their inhibitors in human malignant lymphomas.
Kossakowska AE; Urbanski SJ; Watson A; Hayden LJ; Edwards DR
Oncol Res; 1993; 5(1):19-28. PubMed ID: 8369572
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of angiogenic differentiation of human umbilical vein endothelial cells by curcumin.
Thaloor D; Singh AK; Sidhu GS; Prasad PV; Kleinman HK; Maheshwari RK
Cell Growth Differ; 1998 Apr; 9(4):305-12. PubMed ID: 9563850
[TBL] [Abstract][Full Text] [Related]
8. Interaction with endothelial cells is a prerequisite for branching ductal-alveolar morphogenesis and hyperplasia of preneoplastic human breast epithelial cells: regulation by estrogen.
Shekhar MP; Werdell J; Tait L
Cancer Res; 2000 Jan; 60(2):439-49. PubMed ID: 10667599
[TBL] [Abstract][Full Text] [Related]
9. Human T lymphocytes synthesize the 92 kDa type IV collagenase (gelatinase B).
Weeks BS; Schnaper HW; Handy M; Holloway E; Kleinman HK
J Cell Physiol; 1993 Dec; 157(3):644-9. PubMed ID: 8253876
[TBL] [Abstract][Full Text] [Related]
10. Interaction of endothelial cells with a laminin A chain peptide (SIKVAV) in vitro and induction of angiogenic behavior in vivo.
Grant DS; Kinsella JL; Fridman R; Auerbach R; Piasecki BA; Yamada Y; Zain M; Kleinman HK
J Cell Physiol; 1992 Dec; 153(3):614-25. PubMed ID: 1280280
[TBL] [Abstract][Full Text] [Related]
11. Matrix metalloproteinase 9 (gelatinase B) is expressed in multinucleated giant cells of human giant cell tumor of bone and is associated with vascular invasion.
Ueda Y; Imai K; Tsuchiya H; Fujimoto N; Nakanishi I; Katsuda S; Seiki M; Okada Y
Am J Pathol; 1996 Feb; 148(2):611-22. PubMed ID: 8579123
[TBL] [Abstract][Full Text] [Related]
12. Plasma membrane-dependent activation of gelatinase A in human vascular endothelial cells.
Lewalle JM; Munaut C; Pichot B; Cataldo D; Baramova E; Foidart JM
J Cell Physiol; 1995 Dec; 165(3):475-83. PubMed ID: 7593226
[TBL] [Abstract][Full Text] [Related]
13. Secretion of matrix metalloproteinase-2 (72 kD gelatinase/type IV collagenase = gelatinase A) by malignant human glioma cell lines: implications for the growth and cellular invasion of the extracellular matrix.
Nakagawa T; Kubota T; Kabuto M; Fujimoto N; Okada Y
J Neurooncol; 1996 Apr; 28(1):13-24. PubMed ID: 8740587
[TBL] [Abstract][Full Text] [Related]
14. Secreted inhibitors of metalloproteinases (IMPs) that are distinct from TIMP.
Banda MJ; Howard EW; Herron GS; Apodaca G
Matrix Suppl; 1992; 1():294-8. PubMed ID: 1480040
[TBL] [Abstract][Full Text] [Related]
15. Kupffer cell-derived 95-kd type IV collagenase/gelatinase B: characterization and expression in cultured cells.
Winwood PJ; Schuppan D; Iredale JP; Kawser CA; Docherty AJ; Arthur MJ
Hepatology; 1995 Jul; 22(1):304-15. PubMed ID: 7601425
[TBL] [Abstract][Full Text] [Related]
16. Quantitative reverse zymography: analysis of picogram amounts of metalloproteinase inhibitors using gelatinase A and B reverse zymograms.
Oliver GW; Leferson JD; Stetler-Stevenson WG; Kleiner DE
Anal Biochem; 1997 Jan; 244(1):161-6. PubMed ID: 9025922
[TBL] [Abstract][Full Text] [Related]
17. Tissue inhibitor of metalloproteinases-4 inhibits but does not support the activation of gelatinase A via efficient inhibition of membrane type 1-matrix metalloproteinase.
Bigg HF; Morrison CJ; Butler GS; Bogoyevitch MA; Wang Z; Soloway PD; Overall CM
Cancer Res; 2001 May; 61(9):3610-8. PubMed ID: 11325829
[TBL] [Abstract][Full Text] [Related]
18. Matrix metalloproteinase production by bone marrow mononuclear cells from normal individuals and patients with acute and chronic myeloid leukemia or myelodysplastic syndromes.
Ries C; Loher F; Zang C; Ismair MG; Petrides PE
Clin Cancer Res; 1999 May; 5(5):1115-24. PubMed ID: 10353746
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of tumor invasion of smooth muscle cell layers by recombinant human metalloproteinase inhibitor.
DeClerck YA; Yean TD; Chan D; Shimada H; Langley KE
Cancer Res; 1991 Apr; 51(8):2151-7. PubMed ID: 2009533
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of endothelial cell differentiation on a glycosylated reconstituted basement membrane complex.
Kuzuya M; Satake S; Miura H; Hayashi T; Iguchi A
Exp Cell Res; 1996 Aug; 226(2):336-45. PubMed ID: 8806437
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]